UK’s CMA Drops Part Of Prochlorperazine Probe
But Will Continue To Investigate Alleged Anti-Competitive Overarching Agreement
Executive Summary
The UK’s Competition and Markets Authority has closed “on administrative priorities grounds” its investigation into individual agreements between Alliance Pharmaceuticals, Focus Pharmaceuticals, Medreich and Lexon UK over the supply of prochlorperazine. However, an allegedly anti-competitive “overarching agreement” will continue to be investigated.